Patents by Inventor Sophie Drouillard

Sophie Drouillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220023418
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: October 4, 2021
    Publication date: January 27, 2022
    Applicant: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Patent number: 11135290
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: October 5, 2021
    Assignee: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Patent number: 11090321
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: August 17, 2021
    Assignee: N.V. NUTRICIA
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20200222435
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Application
    Filed: September 20, 2019
    Publication date: July 16, 2020
    Applicant: N.V. Nutricia
    Inventors: Bernd STAHL, Alma Jildou NAUTA, Johan GARSSEN, Eric SAMAIN, Sophie DROUILLARD
  • Publication number: 20200155672
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 21, 2020
    Applicant: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Patent number: 10588965
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: March 17, 2020
    Assignee: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Patent number: 10420784
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: September 24, 2019
    Assignee: N.V. NUTRICIA
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20180264104
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: January 10, 2018
    Publication date: September 20, 2018
    Applicant: N.V. Nutricia
    Inventors: Bernd STAHL, Alma Jildou NAUTA, Johan GARSSEN, Eric SAMAIN, Sophie DROUILLARD
  • Publication number: 20170232022
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Application
    Filed: November 23, 2016
    Publication date: August 17, 2017
    Applicant: N.V. Nutricia
    Inventors: Bernd STAHL, Alma Jildou NAUTA, Johan GARSSEN, Eric SAMAIN, Sophie DROUILLARD
  • Publication number: 20160158346
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: September 29, 2015
    Publication date: June 9, 2016
    Applicant: N.V. Nutricia
    Inventors: Bernd STAHL, Alma Jildou NAUTA, Johan GARSSEN, Eric SAMAIN, Sophie DROUILLARD
  • Publication number: 20120177691
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: July 12, 2010
    Publication date: July 12, 2012
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20120178674
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Application
    Filed: July 12, 2010
    Publication date: July 12, 2012
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20110236934
    Abstract: The present invention relates to the large scale in vivo synthesis of globosides oligosaccharides; especially globotriose, globotetraose and globopentaose, which are the carbohydrate portions of globotriosylceramide (Gb3Cer), globotetraosylceramide (Gb4Cer) and globopentaosylceramide (Gb5Cer) respectively. It also relates to high yield production of potential anticancer vaccines of the globo-series glycosphingo lipids, including the Globo-H.
    Type: Application
    Filed: November 29, 2010
    Publication date: September 29, 2011
    Inventors: Eric Samain, Mialy Randriantsoa, Sophie Drouillard, Tatiana Pierret
  • Publication number: 20070202578
    Abstract: The present invention relates to the large scale in vivo synthesis of globosides oligosaccharides; especially globotriose, globotetraose and globopentaose, which are the carbohydrate portions of globotriosylceramide (Gb3Cer), globotetraosylceramide (Gb4Cer) and globopentaosylceramide (Gb5Cer) respectively. It also relates to high yield production of potential anticancer vaccines of the globo-series glycosphingolipids, including the Globo-H.
    Type: Application
    Filed: August 25, 2006
    Publication date: August 30, 2007
    Inventors: Eric Samain, Mialy Randriantsoa, Sophie Drouillard